|
Ortega-Alvarez D, Tebar-Garcia D, Casado-Pelaez M, Olivares-Osuna D, Castillo-Agea E, Balibrea-Rull J, Barbella-Aponte RA, Perez-Parra D, Musulen E, Guardia C, Vinuesa-Pitarch E, Sanchez-Lopez ME, Postigo-Corrales F, Ballana E, Martinez-Cardus A, Margeli M, Esteller M, Fernandez PL, Luengo-Gil G, Mereu E, Galan-Moya EM, Rodilla V. Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies. Cancer Res. 2026 Feb 11. doi: 10.1158/0008-5472.CAN-24-2758. Online ahead of print. PubMed PMID: 41671401.
AÑO: 2026; IF: 16.6
|
41671401